Search Results
Molecular Reproductive Research Group, Department of Translational Medicine, Lund University, Malmö, Sweden
Institute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden
Search for other papers by Angel Elenkov in
Google Scholar
PubMed
Search for other papers by Irene Leijonhufvud in
Google Scholar
PubMed
Search for other papers by Katerina Vaporidi in
Google Scholar
PubMed
Search for other papers by Åsa Tivesten in
Google Scholar
PubMed
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
hormones in immune responses and inflammatory diseases has been well established. Women are more prone to autoimmune/autoinflammatory diseases than men ( 1 , 2 ). Several factors have been suggested as causes of the differences among men and women in
Search for other papers by Giuseppe Grande in
Google Scholar
PubMed
Search for other papers by Andrea Graziani in
Google Scholar
PubMed
Search for other papers by Antonella Di Mambro in
Google Scholar
PubMed
Search for other papers by Riccardo Selice in
Google Scholar
PubMed
Department of Medicine, University of Padova, Padova, Italy
Search for other papers by Alberto Ferlin in
Google Scholar
PubMed
-analyses have been undertaken to identify additional clinical risk factors that – apart from BMD – may be used in case-finding strategies, to predict the risk of fractures in patients with osteoporosis. The Fracture Risk Assessment tool (FRAX® tool) analyzes
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Mette Bøgehave in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Odense, Denmark
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Jørgen Brodersen Gram in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Else-Marie Bladbjerg in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Johannes Jakobsen Sidelmann in
Google Scholar
PubMed
, physiological doses of testosterone to elderly men with hypogonadism induce no significant change in the coagulation system in terms of tissue factor (TF)-induced thrombin generation ( 20 ), whereas another study in men without hypogonadism points towards a TRT
Search for other papers by Meghnaa Hebbar in
Google Scholar
PubMed
Search for other papers by Halimah Khalil in
Google Scholar
PubMed
Search for other papers by Nawal Zia in
Google Scholar
PubMed
Search for other papers by Jameela Sheikh in
Google Scholar
PubMed
Search for other papers by Eka Melson in
Google Scholar
PubMed
Search for other papers by Meri Davitadze in
Google Scholar
PubMed
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by Tejal Lathia in
Google Scholar
PubMed
Search for other papers by Chitra Selvan in
Google Scholar
PubMed
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Search for other papers by Punith Kempegowda in
Google Scholar
PubMed
Search for other papers by PCOS SEva Working Group in
Google Scholar
PubMed
clinic consultation. Patients are also screened and advised for lifestyle factors: healthy diet, exercise, smoking cessation, and alcohol consumption. Bengaluru, India. This is a tertiary Reproductive Endocrine clinic in a private setting with a
Search for other papers by Zheng Chen in
Google Scholar
PubMed
Search for other papers by Haixia Zeng in
Google Scholar
PubMed
Search for other papers by Qiulan Huang in
Google Scholar
PubMed
Search for other papers by Cuiping Lin in
Google Scholar
PubMed
Search for other papers by Xuan Li in
Google Scholar
PubMed
Search for other papers by Shaohua Sun in
Google Scholar
PubMed
Search for other papers by Jian-ping Liu in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of childbearing age, with an estimated global prevalence of 4–21% ( 1 ). PCOS is a heterogeneous disease that is clinically characterized by oligo
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Lukas Ochsner Ridder in
Google Scholar
PubMed
Department of Clinical Genetics and Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Agnethe Berglund in
Google Scholar
PubMed
Search for other papers by Kirstine Stochholm in
Google Scholar
PubMed
Unit for Thrombosis Research, Hospital of South West Jutland and University of Southern Denmark, Esbjerg, Denmark
Search for other papers by Simon Chang in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Unit for Thrombosis Research, Hospital of South West Jutland and University of Southern Denmark, Esbjerg, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
and diseases in KS males. * Testosterone may possibly positively impact several features of KS ( 12 ). Endocrine diseases with autoimmune components are seen more frequently in KS patients compared to men from the background population. The
Search for other papers by Michael C Velarde in
Google Scholar
PubMed
Search for other papers by Mikaela Erlinda M Bucu in
Google Scholar
PubMed
Search for other papers by Maria Antonia E Habana in
Google Scholar
PubMed
time and develop into a more severe form of the disease. It is important to point out, however, that there are still many factors to consider when comparing incidences and clinical presentations across ethnic groups, as it is still unclear whether these
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Nathalie Ly in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
Introduction Growth hormone (GH) is a pituitary hormone with pleiotropic effects. After being secreted into the general circulation, GH binds to its receptor with subsequent direct effects and insulin-like growth factor (IGF)-mediated effects
Search for other papers by Pamela Stratton in
Google Scholar
PubMed
Search for other papers by Neelam Giri in
Google Scholar
PubMed
Search for other papers by Sonia Bhala in
Google Scholar
PubMed
Search for other papers by Martha M Sklavos in
Google Scholar
PubMed
Search for other papers by Blanche P Alter in
Google Scholar
PubMed
Search for other papers by Sharon A Savage in
Google Scholar
PubMed
Search for other papers by Ligia A Pinto in
Google Scholar
PubMed
the general population, although the risk in DBA is not as high as in FA or DC/TBD ( 4 ). Anti-Müllerian hormone (AMH) is a glycoprotein in the transforming growth factor-β (TGF-β) superfamily ( 16 , 17 ). AMH is a key factor in cell proliferation
Search for other papers by Jennifer K Y Ko in
Google Scholar
PubMed
Search for other papers by Jinghua Shi in
Google Scholar
PubMed
Search for other papers by Raymond H W Li in
Google Scholar
PubMed
Search for other papers by William S B Yeung in
Google Scholar
PubMed
Search for other papers by Ernest H Y Ng in
Google Scholar
PubMed
25(OH)D > 50 and <75 mmol/L in accordance with the Endocrine Society criteria ( 28 ). Serum 25(OH)D levels of >75 nmol/L were considered replete. Women who were vitamin D insufficient and replete were grouped together as the non-deficient group and